Table 1 Major clinicopathologic characteristics of the 100 PC patients
Items | Value, n (%) |
|---|---|
Gender | |
Male/female | 41 (41)/59 (59) |
Age (years) | |
<60/≥60 | 71 (71)/29 (29) |
Median KPS score (range) | 70 (60–90) |
Primary tumor | |
Carcinoma of the stomach | 30 (30) |
Carcinoma of the colorectum | 41 (41) |
Pseudomyxoma peritonei | 13 (13) |
Carcinoma of ovary and primary peritoneum | 16 (16) |
Histopathology | |
Adenocarcinoma, poorly/intermediately differentiated | 44 (44) |
Undifferentiated carcinoma | 3 (3) |
Myxoadenocarcinoma and signet-ring cell carcinoma | 26 (26) |
Serous adencarcinoma | 14 (14) |
Pseudomyxoma peritonei | 13 (13) |
Neoadjuvant chemotherapy | |
Yes/no | 47 (47)/53 (53) |
PC timinga | |
Synchronous/metachronous | 80 (80)/20 (20) |
PCI scoresa | |
≤20/>20 | 44 (44)/56 (56) |
Median PCI scores (range) | 22 (3–39) |
Ascites at surgeryb | |
≤1000 mL/>1000 mL | 63 (63)/37 (37) |
Surgical procedures-organ resection | |
Partial/total gastrectomy | 24 (24) |
Resection of jejunum | 4 (4) |
Resection of ileum | 12 (12) |
Resection of ileocecus | 32 (32) |
Ascending colectomy | 27 (27) |
Transverse colectomy | 32 (32) |
Descending colectomy | 12 (12) |
Sigmoidectomy | 16 (16) |
Rectectomy | 29 (29) |
Resection ovarian/fallopian tube | 29 (29) |
Hysterectomy | 15 (15) |
Partial hepatectomy | 2 (2) |
Splenectomy | 11 (11) |
Cholecystectomy | 11 (11) |
Number of organ resecteda,c | |
1–3 resections | 59 (67.1) |
4–7 resections | 23 (26.1) |
8–12 resections | 6 (6.8) |
Peritonectomya | |
Greater/lesser omentum | 92 (92) |
Left diaphragmatic copula | 15 (15) |
Right diaphragmatic copula | 38 (38) |
Right colon gutter | 41 (41) |
Left colon gutter | 42 (42) |
Liver round ligament/sickle ligament | 53 (53) |
Douglas/rectovesical pouch | 49 (49) |
Anterior wall peritoneum | 40 (40) |
Pelvic peritoneum | 58 (58) |
Mesenteric fulguration | 66 (66) |
Peritoneal resection areaa | |
1–3 resections | 44 (44) |
4–6 resections | 16 (16) |
7–12 resections | 40 (40) |
CC scoresa | |
0 | 30 (30) |
1 | 32 (32) |
2–3 | 38 (38) |
Number of anastomosisa | |
None or ostomy only | 25 (25) |
=1/>1 | 35 (35)/40 (40) |
Postoperative chemotherapy moded | |
SC/SC + IP | 31 (38.3)/50 (61.7) |
Postoperative chemotherapy cycles | |
<6/≥6 | 49 (49)/51 (51) |
Median postoperative chemotherapy cycles (range) | 6 (1–12) |
Median postoperative SC/IP + SC cycles (range)d | 5 (1–12)/6 (1–12) |
Median duration of ICU (hours) (range) | 22 (11–94) |
Median duration of hospitalization (days) (range) | 20 (10–76) |
Median follow-up (months) (range) | 19.7 (7.5–89.2) |